Critical Commitment Provides Continuity

Country Context

Mali has made significant gains in reducing the burden of disease caused by NTDs and has a long history of implementing successful NTD programs. Following a military coup in 2012, funding from the US Agency for International Development (USAID) for NTD control efforts in Mali was frozen. This threatened the time-sensitive NTD work accomplished to date and put the country at risk of reinfection if treatment plans were interrupted. The END Fund was able to step in and garner support from a consortium of visionary investors to ensure the continuation of NTD treatment to millions of people in Mali.

END Fund Investment

In partnership with Helen Keller International (HKI), the USAID technical assistance partner for NTD control, the END Fund supported national integrated NTD treatment in Mali. The program provided NTD treatment for intestinal worms, schistosomiasis, river blindness, and lymphatic filariasis in six southern regions.

Program to Date

In 2013, over 12 million individuals were treated for at least one NTD in Mali. In connection with this, over 27,000 individuals were trained including community drug distributors and health center staff. This program also supported case management and health education activities for those suffering from lymphedema related to LF infection. HKI implemented LF morbidity management activities that included the distribution of hygiene kits and hydrocele surgery for 164 men.